Haisco Pharmaceutical Group Co Ltd (002653):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Haisco Pharmaceutical Group Co Ltd (002653) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7927
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Haisco Pharmaceutical Group Co Ltd (Haisco Pharma), formerly Xizang Haisco Pharmaceutical Group Co Ltd is a developer and marketer of chemical drug preparations. The company offers parenteral nutrition drugs, first-aid drugs, antibiotics, anesthetic agents, nervous system drugs, digestive system drugs and tumor adjuvant drugs. Its parenteral nutrition drugs include compound amino acid injection, injectable fat-soluble vitamins, vitamin and trace element drug, invert sugar injection, trace element injection and injectable fat soluble vitamins. Haisco Pharma’s first-aid drugs comprise cefotene hydrochloride, sodium fusidate, cefmetazole sodium, cefmenoxime hydrochloride and cefoperazone sodium tazobactam sodium. The company conducts research and development of drugs in monoclonal antibodies for anticancer, small molecular patent medicine and novel generic drugs. It operates offices in Shannan and Chengdu, China. Haisco Pharma is headquartered in Shannan, China.

Haisco Pharmaceutical Group Co Ltd (002653) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Haisco Pharmaceutical Group Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Haisco Pharmaceutical Group Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Haisco Pharmaceutical Group Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Haisco Pharmaceutical Group Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Haisco Pharmaceutical Group Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Haisco Pharmaceutical Group Co Ltd, Medical Equipment, Deal Details 10
Venture Financing 10
Regentis Biomaterials Raises USD15 Million in Series D Financing Round 10
Medical Surgery Technologies Raises USD12.5 Million in Series C Financing 12
Equity Offering 13
EndoSpan Raises USD10 Million in Private Placement of Shares 13
Acquisition 14
Xizang Haisco Pharma to Acquire 10% Stake in NewPace for USD5 Million 14
Haisco Pharmaceutical Group Co Ltd – Key Competitors 15
Haisco Pharmaceutical Group Co Ltd – Key Employees 16
Haisco Pharmaceutical Group Co Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Haisco Pharmaceutical Group Co Ltd, Medical Equipment, Key Facts, 2017 2
Haisco Pharmaceutical Group Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Haisco Pharmaceutical Group Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Haisco Pharmaceutical Group Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Haisco Pharmaceutical Group Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Haisco Pharmaceutical Group Co Ltd, Deals By Market, 2012 to YTD 2018 8
Haisco Pharmaceutical Group Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Regentis Biomaterials Raises USD15 Million in Series D Financing Round 10
Medical Surgery Technologies Raises USD12.5 Million in Series C Financing 12
EndoSpan Raises USD10 Million in Private Placement of Shares 13
Xizang Haisco Pharma to Acquire 10% Stake in NewPace for USD5 Million 14
Haisco Pharmaceutical Group Co Ltd, Key Competitors 15
Haisco Pharmaceutical Group Co Ltd, Key Employees 16
Haisco Pharmaceutical Group Co Ltd, Other Locations 17
Haisco Pharmaceutical Group Co Ltd, Subsidiaries 17

List of Figures
Haisco Pharmaceutical Group Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Haisco Pharmaceutical Group Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Haisco Pharmaceutical Group Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Haisco Pharmaceutical Group Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Haisco Pharmaceutical Group Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Haisco Pharmaceutical Group Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Haisco Pharmaceutical Group Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Haisco Pharmaceutical Group Co Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Haisco Pharmaceutical Group Co Ltd (002653):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Polaris Infrastructure Inc (PIF):企業の財務・戦略的SWOT分析
    Summary Polaris Infrastructure Inc (Polaris Infrastructure), formerly Ram Power Corp is a renewable energy company that explores, acquires, operates and develops geothermal energy projects in Latin America. The company owns and operates San Jacinto Tizate Geothermal project, which is located in nort …
  • PTC, Inc. (PTC):企業の財務・戦略的SWOT分析
    PTC, Inc. (PTC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Autodesk Inc:戦略・SWOT・企業財務分析
    Autodesk Inc - Strategy, SWOT and Corporate Finance Report Summary Autodesk Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • ReNeuron Group Plc (RENE):製薬・医療:M&Aディール及び事業提携情報
    Summary ReNeuron Group Plc (ReNeuron) is a clinical-stage stem cell company which develops innovative stem cell therapies targeting areas of significant unmet medical need. The company’s therapeutic candidates in clinical development are focused at treating motor disability as a result of stroke, cr …
  • Precision Optics Corporation Inc (PEYE):企業の財務・戦略的SWOT分析
    Summary Precision Optics Corporation Inc (Precision Optics) is a medical device company that designs, develops, manufactures and distributes optics and optical systems for medical, biomedical, and industrial applications. The company provides custom optics solutions such as design and prototyping, f …
  • W.W. Grainger Inc (GWW):企業の財務・戦略的SWOT分析
    W.W. Grainger Inc (GWW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Calumet Specialty Products Partners, L.P.:企業の戦略・SWOT・財務分析
    Calumet Specialty Products Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Calumet Specialty Products Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • China Metallurgical Group Corp (1618):企業の財務・戦略的SWOT分析
    China Metallurgical Group Corp (1618) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Newfield Exploration Company:企業の戦略・SWOT・財務情報
    Newfield Exploration Company - Strategy, SWOT and Corporate Finance Report Summary Newfield Exploration Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Empresa Nacional de Hidrocarbonetos EP:石油・ガス:M&Aディール及び事業提携情報
    Summary Empresa Nacional de Hidrocarbonetos EP (ENH) is an oil and gas company that explores, produces and markets petroleum products. The company conducts research, exploitation, production, refining, transportation, storage and marketing of hydrocarbons and its derivatives such as liquefied natura …
  • Tesla Energy Operations Inc:企業の戦略的SWOT分析
    Tesla Energy Operations Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • PellePharm Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary PellePharm Inc (PellePharm), a subsidiary of BridgeBio Inc, is a biotechnology company that develops and commercializes treatments for rare genetic dermatological conditions. The company’s lead clinical program, Patidegib, is a first-in-class topical gel formulation of a proprietary hedgehog …
  • Texas A&M University-製薬・医療分野:企業M&A・提携分析
    Summary Texas A&M University (TAMU) is a research based university that offers educational and research services. The university provides undergraduate, graduate and professional courses to its students. It consists of various colleges and departments such as College of Agriculture and Life Sciences …
  • Walmart Chile S.A.:企業の戦略的SWOT分析
    Walmart Chile S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • McDermott International, Inc.:企業の戦略・SWOT・財務情報
    McDermott International, Inc. - Strategy, SWOT and Corporate Finance Report Summary McDermott International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Valmet Corp (VALMT):企業の財務・戦略的SWOT分析
    Valmet Corp (VALMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Mizuho Financial Group Inc:企業の戦略・SWOT・財務情報
    Mizuho Financial Group Inc - Strategy, SWOT and Corporate Finance Report Summary Mizuho Financial Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • 7-Eleven Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary 7-Eleven, Inc (7-Eleven) a subsidiary of Seven-Eleven Japan Co., Ltd., is a convenience store chain operator. The company operates through franchise and license models and offers a range of merchandises. It also operates as an independent gasoline retailer. The company’s store offers various …
  • Sprint Bioscience AB (SPRINT):製薬・医療:M&Aディール及び事業提携情報
    Summary Sprint Bioscience AB (Sprint Bioscience) is a developer of pharmaceutical products in the areas of cancer and metabolism. The company develops STK25, a drug candidate against a new target protein for the treatment of type 2 diabetes; VPS34, a drug candidate for the treatment of various types …
  • UGE International Ltd (UGE):電力:M&Aディール及び事業提携情報
    Summary UGE International Ltd (UGE), formerly Way Ventures Inc, is a renewable energy company that operates through wind, solar, solar-wind technologies. The company’s products include electronics and accessories, wind turbines, solar panels, energy storage systems, mounting system, electronics, and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆